Clinical Investigator Training Program


Hematology/Oncology

We offer a clinical research track for fellows interested in careers as clinical investigators. Formal training in clinical research can be obtained through early involvement in ongoing clinical trials within the institution. Fellows may participate in the development of new institutional protocols and may conduct retrospective hypothesis-driven studies. In addition, we strongly encourage fellows in the clinical research track to pursue advanced degrees in clinical research or epidemiology.

Here are examples of clinical research publications by fellows of the Pediatric Hematology Oncology Program.

Nottage K, Lanctot J, Li Z, Neglia JP, Bhatia S, Hammond S, Leisenring W, Meadows AT, Srivastava DK, Robison LL, Armstrong GT. Long-Term Risk for Secondary Leukemia after Treatment for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Blood June 9; 117(23):6315-8, 2011.

Phillips G, Baker JN, Johnson LM, Boop F, “Mistakes were made”: A case discussion concerning surrogate decision making and end of life care. In Press, AANS Neurosurgeon, 2011.

Johnson LM, Baker JN. Pediatric POLST: getting it right in the emergency department. American Academy of Pediatrics, Committee on Bioethics, Fall 2011. American Academy of Pediatrics Subcommittee on Bioethics Essay Contest Awardee

Estepp JH, Smeltzer M, and Reiss UM. Effect of ‘Therapeutic’ Anticoagulation with Low-Molecular-Weight-Heparin on Recurrent Venous Thrombosis in Children. Poster session: 24th Annual Meeting of the American Society of Pediatric Hematology and Oncology; 2011 Apr 13-16th; Baltimore, MD.

Estepp J, Smeltzer M, Reiss UM. The Impact of Quality and Duration of Enoxaparin Therapy on Recurrent Venous Thrombosis in Children. Pediatric Blood and Cancer; Forthcoming 2011-2012.

Sullivan E, Jeha S. 50 Years Ago in The Journal of Pediatrics: Chickenpox and Leukemia. The Journal of Pediatrics 158(5):783, 2011.

Federico S, Brennan R, Dyer MA. Childhood cancer and developmental biology a crucial partnership. Curr Top Dev Biol 94:1-13, 2011.

Brennan R, Helton K, Pei D, Cheng C, Inaba H, Metzger M, Howard S, Rubnitz J, Ribeiro R, Sandlund J, Jeha S, Pui C-H, Bhojwani D. Spinal epidural lipomatosis in children with hematologic malignancies. Ann Hematol Feb 22, 2011. [Epub ahead of print]

Baker JN, Rai S, Liu W, Srivastava K, Kane JR, Zawistowski CA, Burghen EA, Gattuso JS, West N, Althoff J, Funk A, Hinds PS. Race does not influence do-not-resuscitate status or the number or timing of end-of-life care discussions at a pediatric oncology referral center. J Palliat Med Jan;12(1):71-6, 2009.

Hankins JS, Jeng M, Harris S, Li SC; Liu T, Wang W. Chronic transfusion for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol 27:158–161, 2005.

Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP, Wang WC. Long-term Hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood 106(7):2269-75, 2005.

Hartford CM, Wodowski KS, Rao BN, Khoury JD, Neel MD, Daw NC. Osteosarcoma among children aged 5 years or younger: the St. Jude Children’s Research Hospital experience. J Pediatr Hematol Oncol 28(1):43-47, 2006

Wright KD, Green DM, Daw NC. Late effects of treatment for Wilms tumor. Pediatr Hematol Oncol Sept; 26(6): 407-13, 2009

Shook D, Coustan-Smith E, Ribeiro RC, Rubnitz JE, Campana D. Minimal residual disease quantitation in acute myeloid leukemia. Clinical Lymphoma, Myeloma & Leukemia 9(Suppl 3):S281-285, 2009.

Metzger ML, Howard SC, Fu LC, Pena A, Stefan R, Hancock ML, Zhang Z, Pui CH, Wilimas J, Ribeiro RC. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. 362: 706-708, 2003.